---
title: "Eikon Therapeutics, Inc. (EIKN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/EIKN.US.md"
symbol: "EIKN.US"
name: "Eikon Therapeutics, Inc."
industry: "Biotechnology"
---

# Eikon Therapeutics, Inc. (EIKN.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [eikontx.com](https://eikontx.com) |

## Company Profile

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs using a platform that permits precise characterization of protein interactions in living cells. Its products include EIK1001, a systemically a...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.31 | 268/602 | - | - | - |
| PB | -1.29 | 490/602 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-26T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 13.78 |
| Highest Target | 7.00 |
| Lowest Target | 7.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/EIKN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/EIKN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/EIKN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.